These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21890273)

  • 1. Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain.
    Sasso O; Russo R; Vitiello S; Raso GM; D'Agostino G; Iacono A; La Rana G; Vallée M; Cuzzocrea S; Piazza PV; Meli R; Calignano A
    Pain; 2012 Jan; 153(1):33-41. PubMed ID: 21890273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.
    Raso GM; Esposito E; Vitiello S; Iacono A; Santoro A; D'Agostino G; Sasso O; Russo R; Piazza PV; Calignano A; Meli R
    J Neuroendocrinol; 2011 Jul; 23(7):591-600. PubMed ID: 21554431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis.
    Sasso O; La Rana G; Vitiello S; Russo R; D'Agostino G; Iacono A; Russo E; Citraro R; Cuzzocrea S; Piazza PV; De Sarro G; Meli R; Calignano A
    Eur Neuropsychopharmacol; 2010 Mar; 20(3):195-206. PubMed ID: 19864116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
    Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
    Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thickening network of lipids.
    Piomelli D
    Pain; 2012 Jan; 153(1):3-4. PubMed ID: 22019134
    [No Abstract]   [Full Text] [Related]  

  • 6. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
    D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
    Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of Peroxisome Proliferator-Activated Receptor-α by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior.
    Locci A; Pinna G
    Biol Psychiatry; 2019 Jun; 85(12):1036-1045. PubMed ID: 30955840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.
    Luongo L; Guida F; Boccella S; Bellini G; Gatta L; Rossi F; de Novellis V; Maione S
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):45-54. PubMed ID: 23394524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats.
    Naderi N; Majidi M; Mousavi Z; Khoramian Tusi S; Mansouri Z; Khodagholi F
    Neurochem Res; 2012 Apr; 37(4):778-85. PubMed ID: 22201038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
    Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
    Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of PPARα in the spinal cord contributes to augmented peripheral inflammation and inflammatory hyperalgesia in diet-induced obese rats.
    Wang J; Zhang Q; Zhao L; Li D; Fu Z; Liang L
    Neuroscience; 2014 Oct; 278():165-78. PubMed ID: 25135355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
    Impellizzeri D; Bruschetta G; Cordaro M; Crupi R; Siracusa R; Esposito E; Cuzzocrea S
    J Neuroinflammation; 2014 Aug; 11():136. PubMed ID: 25164769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
    Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
    J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
    Ardizzone A; Fusco R; Casili G; Lanza M; Impellizzeri D; Esposito E; Cuzzocrea S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.
    Di Cesare Mannelli L; D'Agostino G; Pacini A; Russo R; Zanardelli M; Ghelardini C; Calignano A
    Mediators Inflamm; 2013; 2013():328797. PubMed ID: 23533304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
    Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
    FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.
    D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Raso GM; Cuzzocrea S; Lo Verme J; Piomelli D; Meli R; Calignano A
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1137-43. PubMed ID: 17565008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylethanolamide relieves pain and preserves pancreatic islet cells in a murine model of diabetes.
    Donvito G; Bettoni I; Comelli F; Colombo A; Costa B
    CNS Neurol Disord Drug Targets; 2015; 14(4):452-62. PubMed ID: 25921749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.